Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control.
about
MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.Effect of angiotensin II type 1 receptor blocker and angiotensin converting enzyme inhibitor on the intraocular growth factors and their receptors in streptozotocin-induced diabetic rats.Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension.Vitamin D Deficiency Is Not Associated with Diabetic Retinopathy or Maculopathy.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Therapeutic targets of renin-angiotensin system in ocular disorders.Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-(1-12) axis in the Pathogenesis of Diabetic Retinopathy.Many Faces of Renin-angiotensin System - Focus on Eye.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.The TetO rat as a new translational model for type 2 diabetic retinopathy by inducible insulin receptor knockdown.Effects of Diets with Different Proportions of Protein/Carbohydrate on Retinal Manifestations in db Mice.
P2860
Q30844796-EEAA7760-645D-48AF-8265-531F46723688Q33914589-498E7DFE-245D-4558-996B-8B290438C53EQ35751342-2E977F2E-0FC3-4F9D-893B-7C6E9B6C1A03Q36537266-6F0A98D6-F4BD-47A6-9628-ED2528785FDAQ39103248-0CE36489-ECEC-4E22-A5DA-31D610D5EA54Q39214578-3E65224B-28B6-4998-B793-B92FABF31790Q39238324-BB9C543A-2F2B-40B7-B5BD-A6A464899F42Q41015495-8CA786E8-0308-462D-BE5F-6F60DC3B36CCQ45072634-9DF2B813-CDFB-4B89-B089-AF973D0C99C9Q50947386-37C206E3-685F-4438-916E-6D804D9C2EFDQ51430597-B1B4DBB5-D48F-412E-8045-643B8B895BD8Q55270087-954E8427-FA24-4D30-989B-9A247A0B2196
P2860
Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Benefits of Renin-Angiotensin ...... es vary with glycemic control.
@ast
Benefits of Renin-Angiotensin ...... es vary with glycemic control.
@en
type
label
Benefits of Renin-Angiotensin ...... es vary with glycemic control.
@ast
Benefits of Renin-Angiotensin ...... es vary with glycemic control.
@en
prefLabel
Benefits of Renin-Angiotensin ...... es vary with glycemic control.
@ast
Benefits of Renin-Angiotensin ...... es vary with glycemic control.
@en
P2093
P2860
P356
P1433
P1476
Benefits of Renin-Angiotensin ...... es vary with glycemic control.
@en
P2093
Alan Sinaiko
M Luiza Caramori
Michael Mauer
Renin Angiotensin System Study (RASS) group
Tasma Harindhanavudhi
P2860
P304
P356
10.2337/DC11-0476
P407
P577
2011-06-29T00:00:00Z